Gerresheimer at Pharmapack 2024: Innovative solutions and expert presentations

  • Broad portfolio for biologics, including cell and gene therapy products 
  • Digitally connected Drug Delivery Devices for self-administration 
  • New performance levels for the right choice of product 
  • Sustainability by design from development to production 

Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industry will present its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at this year’s Pharmapack. The company’s presence at the trade fair will focus on specialized primary packaging solutions for sensitive innovative drugs such as biopharmaceuticals, including cell and gene therapy products — from COP injection vials for cryogenic temperatures through to medication pumps. Thanks to its extensive portfolio and long-standing expertise, Gerresheimer delivers the right solution for every drug and every production requirement, including RTF solutions that minimize risks during the filling process, reduce overall costs and accelerate time to market. Alongside its own efforts to increase sustainability, Gerresheimer helps customers take this topic into account as early as during the product development stage through its EcoDesign approach. On top of that, the company provides sterilization and RTF packaging options that are more environmentally friendly. Gerresheimer will be presenting its solutions at Pharmapack Paris from January 24 – 25 in hall 7.2, booth F60 and in the Innovation Gallery. Gerresheimer experts will also share insights and expertise in innovation track presentations and learning lab sessions. 

"Highlights of our portfolio, which we will presenting at Pharmapack 2024, include our latest solutions that meet the highest requirements of complex drug formulations, therapies, and fill & finish processes”, says Dr. Lukas Burkhardt, member of the Gerresheimer Management Board 

Gerresheimer Conference Highlights at Innovation Track and Learning Lab
Gerresheimer experts will share insights and expertise several innovation track presentations and learning lab sessions: 

Opportunities and Challenges in Connected Drug Delivery
Date: 24th January, Time: 11.30 – 11.40 h
Venue: Conference Theatre, Room 721
Speaker: Mithun Ratnakumar, Director Technology Strategy & Governance at Gerresheimer 

Challenges of subcutaneous drug delivery for self-administration
Date: 24th January, Time: 11.55 – 12.20 h
Venue: Conference Theatre, Room 721
Speaker: Oliver Haferbeck, Global Senior Vice President Innovation Advanced Technologies at Gerresheimer 

Gerresheimer performance levels for the right choice of product platform
Date: 24th January, Time: 15.50 – 16.20 h
Venue: Learning Lab Theatre, L20
Speakers: Stefan Verheyden, Global Vice President Biological Solutions and Syringes, and Holger Krenz, Global Vice President Business Development High Value Products Tubular Glass at Gerresheimer 

Joint Session with Sterigenics – new option for sterilizing prefilled ophthalmic syringes
Date: 25th January, Time: 10:10 – 10:40
Venue: Learning Lab Theatre, L20
Speakers: Bernd Zeiss, Head of Scientific Affairs and Application Technologies at Gerresheimer, and Eric Offermann, Principal Scientist R&D Sterigenics 

Gerresheimer at Pharmapack Paris
Gerresheimer presents its portfolio at Pharmapack, Paris Expo, Porte de Versailles, from January 24-25, 2024, in Hall 7.2 at booth F60.  

Interested trade visitors can schedule an appointment with one of the Gerresheimer experts at www.gerresheimer.com/en/pharmapack-2024.

Über die Gerresheimer AG

Gerresheimer is an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical containment solutions, drug delivery systems and medical devices as well as solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. With 36 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. With over 11,000 employees, the company generated revenues of around €1.82bn in 2022. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).  

www.gerresheimer.com

Firmenkontakt und Herausgeber der Meldung:

Gerresheimer AG
Klaus-Bungert-Straße 4
40468 Düsseldorf
Telefon: +49 (211) 6181-00
Telefax: +49 (211) 6181-295
http://www.gerresheimer.de

Ansprechpartner:
Marion Stolzenwald
Senior Manager Group Communication
Telefon: +49 (211) 6181-246
Fax: +49 (211) 6181-241
E-Mail: m.stolzenwald@gerresheimer.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel